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Abstract
Background: Telephone-based care management programmes have been shown to improve health outcomes in
some chronic diseases. Birmingham Own Health
® is a telephone-based care service (nurse-delivered motivational
coaching and support for self-management and lifestyle change) for patients with poorly controlled diabetes,
delivered in Birmingham, UK. We used a novel method to evaluate its effectiveness in a real-life setting.
Methods: Retrospective cohort study in the UK. 473 patients aged ≥ 18 years with diabetes enrolled onto
Birmingham Own Health
® (intervention cohort) and with > 90 days follow-up, were each matched by age and sex
to up to 50 patients with diabetes registered with the General Practice Research Database (GPRD) to create a pool
of 21,052 controls (control cohort). Controls were further selected from the main control cohort, matching as close
as possible to the cases for baseline test levels, followed by as close as possible length of follow-up (within +/-30
days limits) and within +/-90 days baseline test date. The aim was to identify a control group with as similar
distribution of prognostic factors to the cases as possible. Effect sizes were computed using linear regression
analysis adjusting for age, sex, deprivation quintile, length of follow-up and baseline test levels.
Results: After adjusting for baseline values and other potential confounders, the intervention showed significant
mean reductions among people with diabetes of 0.3% (95%CI 0.1, 0.4%) in HbA1c; 3.5 mmHg (1.5, 5.5) in systolic
blood pressure, 1.6 mmHg (0.4, 2.7) in diastolic blood pressure and 0.7 unit reduction (0.3, 1.0) in BMI, over a mean
follow-up of around 10 months. Only small effects were seen on average on serum cholesterol levels (0.1 mmol/l
reduction (0.1, 0.2)). More marked effects were seen for each clinical outcome among patients with worse baseline
levels.
Conclusions: Despite the limitations of the study design, the results are consistent with the Birmingham Own
Health
® telephone care management intervention being effective in reducing HbA1c levels, blood pressure and
BMI in people with diabetes, to a degree comparable with randomised controlled trials of similar interventions and
clinically important. The effects appear to be greater in patients with poorer baseline levels and the intervention is
effective in the most deprived populations.
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Increasing numbers of people worldwide are living with a
long-term condition such as diabetes, heart failure and
heart disease. Poorly controlled chronic conditions can
lead to more rapid deterioration, complications, poor
q u a l i t yo fl i f ea n di n t e n s i v eu s eo ft h eh e a l t hs e r v i c e s .
T h ee m p h a s i so fc a r ei nt h eU Kh a sn o wc h a n g e df r o m
being predominantly reactive to a more preventive man-
agement approach [1], with the aim of reducing emer-
gency hospital admissions and encouraging patients to
make healthier choices about diet, physical activity and
lifestyle through self-management of their condition [2].
Approximately 2.7% of adults aged 20-64 years in
England have diagnosed diabetes [3]. People with diabetes
have a high risk of cardiovascular mortality and therefore
control of cardiovascular risk factors is essential to preven-
tion. Although the primary care management of diabetes
has changed to meet newer guidelines and control of blood
pressure and cholesterol have improved, glycaemic control
and obesity levels have not [4,5].
Systematic reviews have shown that some interventions
may produce improvements in disease management
[6-12], but in general, further research is required as to
the best method of delivery to attain sustained improve-
ments in glucose control and other outcomes.
Care management programmes using the telephone
have been shown in other chronic diseases, such as heart
failure and coronary heart disease, to improve some health
outcomes and also reduce health service use [13-15]. They
offer an attractive easy-access, inexpensive approach.
There are several published studies of telephone care man-
agement of people with diabetes, although few good qual-
ity RCTs [9]. A cluster RCT in the US [16] (IDEATel) of
1665 Medicare recipients aged 55 years and older with
diabetes showed that in the intervention group (nurse case
manager, video conferencing, glucose and BP monitoring,
educational website and some coaching/motivational
aspect) at 1 year, there were significant improvements in
HbA1c (0.18% p = 0.0006), SBP, DBP, total and LDL cho-
lesterol compared with the control group. An RCT in
Salford of Pro-Active Call Centre Treatment Support
(PACCTS) in 591 patients with type 2 diabetes (patient
education, metabolic management, motivational techni-
ques, customised frequency of contacts) showed a signifi-
cant improvement in HbA1c compared with controls at
1 year. However, the effect was mainly seen in patients
with > 7% HbA1c at baseline, with a relative improvement
of 0.49% [17].
Birmingham Own Health
® is a bespoke telephone-
based care management service for patients with poorly-
controlled diabetes, based in Birmingham East and North
Primary Care Trust, and led by nurses who provide moti-
vational coaching and support for self-management and
lifestyle changes within a personalized care plan. In this
resource-scarce environment, it is essential that new
services are properly evaluated. As the service was
already in place, it was not possible to undertake a rando-
mised controlled trial. In order to compare its effective-
ness against usual care, we used the General Practice
Research Database (GPRD) in a unique way, obtaining a
matched cohort of patients and comparing a range of
clinical indicator outcomes.
Methods
Study design
Retrospective cohort study comparing Birmingham Own
Health
® patients, receiving their personalised telephone
care intervention, with a matched control cohort from the
General Practice Research Database (GPRD), receiving
usual care.
Intervention cohort
Description of Birmingham Own Health
® intervention
Birmingham Own Health
® is a “bespoke disease manage-
ment programme which supports individuals with long-
term conditions to make changes in their daily behaviour
that will have a positive impact on their health and will
encourage more appropriate use of NHS services” [18]. It
is a partnership between Birmingham East and North
PCT, Pfizer Health Solutions and NHS Direct, commis-
sioned in 2005 to deliver care management support by
telephone to patients with diabetes, cardiovascular disease
and heart failure. This paper refers to patients with
diabetes. Patients are recommended by their GP according
to need; those with poorly controlled conditions are
referred and contacted directly, although they may
“opt-out” when approached. Each consenting individual is
assigned a care manager (specifically trained nurses
employed by NHS Direct), and together they develop a
personalized care plan with support from decision-support
software. Care managers make pro-active telephone calls
and provide motivational coaching with stage-based coun-
selling and support for self-management (including adher-
ence to medication and treatment goals) and lifestyle
change (such as diet and exercise). Care managers follow
five fundamental steps: assessment, recommendation,
follow-up, ongoing monitoring and evaluation. Several key
recommendations were used to underpin the decision-
support software tool, developed from evidence-based
literature and consensus guidelines, including that of the
Joint British Societies 2 (2005) [19], and National Service
Framework for Diabetes [20]. The target for HbA1c was <
6.5%; for blood pressure < 130/80; total cholesterol
< 4.0 mmol/L (or ≥ 25% reduction); BMI 18.5-24.9.
The nurses receive a six-week training process which
includes all aspects of care-management and education
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service. Although there is a broad protocol covering the
8 self-management priorities (see below), they are
trained to provide telephone-based advice which is com-
pletely individual and tailored to each person’s condition
and circumstances, providing supportive not directive
care management, allowing each individual to set their
own goals. Nurses have a robust clinical background
and are trained to work with the primary care team
where needed.
Birmingham Own Health
® eight self-management
priorities:
1. Know how and when to call for help
2. Learn about the condition and set goals
3. Take medicines correctly
4. Get recommended tests and services
5. Act to keep the condition well-controlled
6. Make lifestyle changes and reduce risks
7. Build on strengths and overcome obstacles
8. Follow-up with specialists and appointments
Care managers are able to discuss with the healthcare
staff from the patient’s general practice to help understand
their patient’s condition and can also make referrals for
review. Participants also receive educational materials and
a hand-held record book. They remain in the programme
for nine months, with 1-2 calls per month of varying
length (according to need). At this stage, they undertake a
care-review where they may “graduate” or remain in the
programme. It is based on the “Green Ribbon” model
designed in the US [21]. The programme began recruiting
on 1/4/2006 and is ongoing.
Population receiving Birmingham Own Health
® intervention
Patients were eligible for the Birmingham Own Health
®
diabetes module if they were aged 18 years and over,
were on the diabetes mellitus register, had access to a
telephone, and at least one of the following:
￿ Cholesterol ≥ 5 mmol/l (due to non-compliance
with their medication)
￿ CHD or Stroke/TIA registry
￿ Hypertension registry or BP > 150/90
￿ Complication of retinopathy, micro or overt protei-
nuria, lower extremity amputation or ulcer, diabetic
neuropathy
￿ Assessed by clinician as likely to benefit from the
service (because of poor compliance)
Patients with diabetes were also included if they had
heart failure or cardiovascular disease and had been
referred to Birmingham Own Health
® for those condi-
tions. Inclusion was not dependent on medications
received.
Population included in these analyses
This is an ongoing service and therefore participants had
experienced differing amounts of time in the programme.
In order to give reasonable time for some effect, partici-
pants were only included in the analyses for this study if
they had ≥ 90 days follow-up data for the outcome of
interest. This sub-group had many characteristics similar
to that of the whole Birmingham Own Health group
except for smoking status where information was more
complete, and also there were higher reported levels of
depression, and use of beta-blockers, diuretics, statins and
insulin. The first recorded data for each outcome was clas-
sified as the baseline data, and the latest recorded data
before 31/12/2007 as their final data. Any data before 1/4/
2006 was carried forward to 1/4/2006 as this was when
the intervention commenced.
Descriptive data obtained
Information on demographic details, smoking history,
other medical conditions and medications were obtained
by self-report. Baseline clinical data were obtained directly
from the GPs, although outcome data were obtained by
self-report, where patients took a hand-held booklet to
their GP to record measurements and tests (this should
reflect confidential GP records). A measure of deprivation
(Index of Multiple Deprivation 2004) was obtained for the
ward of the GP practice of the patient. Patients with miss-
ing deprivation scores were assigned quintile 5 as the
intervention was directed towards practices in the most
deprived areas.
Control cohort
General Practice Research Database (GPRD)
Controls were obtained from the GPRD. The GPRD is a
computerised database of anonymised longitudinal medi-
cal records from about 488 general practices (over 3.6 mil-
lion existing patients) throughout the UK, including
patient demographics, medical diagnoses, prescription
information, referral and treatment outcomes [22]. The
population included in the database is broadly representa-
tive of the demographic breakdown of the UK population.
The data has been used for cross-sectional, case-control
and cohort analyses. Over 1.4 million patients in the data-
base have more than 11 years data available.
Selection of control cohort
Phase I: Selection of a large pool of controls
Patients were selected from the GPRD for the control
cohort if they met the following criteria:
￿ Registered with general practices in England contri-
buting to the GPRD at an “up-to-standard” quality
level from two months prior to 1/4/2005 (excluding
practices involved in Birmingham Own Health
®
Intervention)
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￿ Diagnosed with diabetes mellitus before 1/04/
2005
￿ Alive and with complete follow-up at 31/12/2007.
It was not possible to identify patients with poor dis-
ease control from the GPRD data.
Exclusion criteria were derived from that used for the
Birmingham Own Health
® Intervention and therefore
the following were excluded:
￿ Patients with a diagnosis of dementia in the last
5y e a r s
￿ Patients with diagnosis of schizophrenia or manic
depression or a prescription for treatment with anti-
psychotics in the last 5 years
￿ Patients with a record of drug addiction or a pre-
scription record for methadone in the last 5 years
￿ Women with a record of pregnancy in the last 5
years
￿ Patients with a terminal condition such as Parkinson’s
Disease, motorneurone disease, Huntingdon’s chorea,
or any malignant cancer in the last 5 years
￿ Patients with renal dialysis or prescription of anti-
retroviral therapy (to indicate HIV) or HIV diagnosis
in the last 5 years
The process of selecting matched controls is illustrated
in Figure 1. Up to 50 GPRD patients per patient in the
intervention cohort were selected to form the control
pool, matched on year of birth and sex. There were insuffi-
cient GPRD patients with diabetes to also match on depri-
vation quintile. Codelists used to search the GPRD for
each condition were selected in collaboration with the
GPRD and were designed to be inclusive (these are avail-
able from the authors on request).
Phase II: further selection of controls for each outcome
Each outcome was evaluated separately. Controls were
further selected from the main pool, matching as close as
possible to the cases for baseline test levels, followed by as
close as possible length of follow-up (within +/-30 days
limits) and within +/-90 days baseline test date. Duplicate
controls were removed so that each control contributed
only once to each outcome. There was no limit to the
number of controls selected per case. The aim was to
identify a control group with as similar distribution of
prognostic factors to the cases as possible.
Descriptive information extracted from the GPRD
Information on demographic details, smoking history,
other medical conditions and medications was extracted.
Smoking status within the GPRD was classified as latest
reported before 1/4/2006. However in order to reduce
misclassification of reported never smoking controls from
the GPRD, prior records were searched to capture “ever
smokers”. Medication use within the GPRD was that
recorded in the two years prior to 1/4/2006.
Outcomes
The primary outcomes were glycosylated haemoglobin
(HbA1c), systolic (SBP) and diastolic blood pressure (DBP),
total serum cholesterol and Body Mass Index (BMI).
Statistical analyses
The effect of the intervention on the primary outcomes
was evaluated using least-squares linear regression of
final values, presenting mean differences (with 95% con-
fidence intervals) adjusted for age, sex, smoking history,
and baseline levels of blood pressure, HbA1c, choles-
terol, BMI (as appropriate for that outcome) (ie an
ANCOVA approach). Sub-group analyses were con-
ducted according to age, sex, deprivation quintile, base-
line test levels and length of follow-up.
Ethical approval
Ethical approval was obtained from the University of
Birmingham ethics committee and approval to use
GPRD data was obtained from the Independent Scienti-
fic Advisory Committee (ISAC). The chairman of Bir-
mingham East and North Local Research Ethics
Committee approved the use of the Birmingham Own
Health
® data as a service evaluation.
Results
Characteristics of patients
Characteristics of both the intervention and control
patients are given in Table 1. Of a total of 1195 partici-
pants enrolled on the intervention, 473 had at least 90
days follow-up for one or more of the primary outcomes.
The 473 included participants were compared to con-
trols taken from a pool of 21,052 matched control patients
identified from the GPRD. The intervention group had a
similar age and sex profile to the control group, although
had a greater number of current smokers and a different
deprivation profile. Although many of the comorbidities
and medications had similar rates between the two
cohorts, those in the Birmingham Own Health cohort
reported lower rates of asthma and COPD, although
higher rates of depression, use of diuretics and insulin.
In addition, there was a greater proportion of partici-
pants in Birmingham Own Health
® with heart disease
(37.0% were also enrolled on the CHD or heart failure
modules) compared with those identified as having
heart disease from the GPRD (19.9%).
Effect of Birmingham Own Health
® intervention among
people with diabetes
Table 2, Table 3, Table 4 and Table 5 indicate the effect of
the Birmingham Own Health
® Intervention on people
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age length of follow-up ranged between 296 days (8
months) and 336 days (11 months) depending on the out-
come. For all outcomes except serum cholesterol, patients
in the intervention group had slightly higher baseline
values than those in the control group. Patients receiving
the intervention showed reductions for each of the out-
comes over the follow-up period, although patients in the
control group remained relatively stable over time in com-
parison. After adjusting for baseline values and other
potential confounders, the intervention showed significant
mean reductions of 0.3% (95%CI 0.1, 0.4%) in HbA1c; 3.5
mmHg (1.5, 5.5) in systolic blood pressure and 1.6 mmHg
(0.4, 2.7) in diastolic blood pressure, and 0.7 kg/m
2 reduc-
tion in BMI (0.3, 1.0). The effect on serum cholesterol
(reduction of 0.1 mmol/l (0.1, 0.2)) was relatively smaller
but remained significant. For each of the outcomes, poorer
baseline values tended to lead to larger reductions, with
patients with ≥ 8.0% HbA1c at baseline experiencing 0.4%
improvement over the period of the study, those with SBP
of ≥ 150 a reduction of 5.4 mmHg, and those with high
BMI of ≥ 40 a 2.9 point reduction.
Birmingham Own Health
Intervention Cohort with diabetes
N=1195
GPRD Control cohort
selected from those registered with diabetes
Up to 50 patients per patient in intervention
cohort
Matched for year of birth and sex
N=21052
PHASE I CONTROL
SELECTION
HbA1c endpoints
N=296
Blood pressure
endpoints
N=288
Serum cholesterol
endpoints
N=239
BMI endpoints
N=307
HbA1c endpoints
N=3454
Blood pressure
endpoints
N=4789
Serum cholesterol
endpoints
N=1961
BMI endpoints
N=2738
PHASE II SELECTION OF
CONTROLS
MATCHED TO
INTERVENTION
COHORT FOR BASELINE
TEST LEVELS, LENGTH
OF FOLLOW-UP AND
BASELINE TEST DATE
>90 days follow-up
Included in the analyses
N=473
Figure 1 Flow chart indicating matching and selection of controls from the GPRD.
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Repeating the analyses restricting to participants from
the two most deprived quintiles had little effect on the
results (data not shown). Females had a tendency to
achieve greater improvements in blood pressure (5.1/2.5
mmHg SBP/DBP compared with 2.1/0.8 in males), and
a possible greater reduction in BMI (1.4 among females,
compared with 0.1 points among males). Other than the
reduction in blood pressure, where the intervention may
have had greater immediate effects (3-6 mths) than in
the longer term, there was no consistent effect of length
of follow-up. The reduction in HbA1c was more marked
among those aged 65 years and over (0.4% (95%CI 0.2,
0.6%) than among those younger than 65 years (0.2%
(95%CI 0.0, 0.3%)).
Discussion
A sf a ra sw ea r ea w a r e ,t h eu s eo ft h eG P R Dt oo b t a i n
controls is a novel way to evaluate public health interven-
tions. We found that participants with diabetes in the
Birmingham Own Health
® intervention had both statisti-
cally and clinically significantly lower HbA1c and blood
pressure and BMI over an average 10 months follow up,
compared to matched controls from the GPRD. The
overall effect on total cholesterol was slightly lower, but
still statistically significant. Furthermore, in line with
other studies [17], those with poorest levels of control at
baseline showed the highest level of improvement, again
compared to matched controls.
The magnitude of effect for some of the clinical end-
points was similar to that seen in randomised controlled
trials of similar interventions. Although also including
different elements (eg videoconferencing, telemonitoring)
the IDEATel trial of 1,665 people with diabetes identified
through disadvantaged primary care practices in New
York, found very similar reductions in HbA1c (-0.18%),
SBP (-3.4 mmHg) and DBP (-1.9 mmHg) at one year
[16], to those seen in our study among intervention,
compared to control participants. A recent follow-up
study found that the benefits in terms of HbA1c, choles-
terol and blood pressure were maintained after 5 years,
although there were no differences in mortality rates
between control and intervention groups [11]. Similarly
the PACCTS trial (telephone care management in Sal-
ford) comprising 591 people with diabetes from primary
care, showed similar results, with reductions in HbA1c of
-0.31% (and -0.49% in those with HbA1C ≥ 7.0% at base-
line) in the intervention compared to the usual care arm
[17]. Systematic reviews of self-management interven-
tions have shown that mean reductions in HbA1c range
from 0.26% [23], 0.45% [24] to 0.81% [25]. The reviews
suggest that intervention effects reduce over time [23],
and that regular re-enforcement during follow-up and
interventions that involve patient collaboration are more
likely to succeed [23]. Cardiovascular outcomes including
blood pressure change are less frequently reported in
self-management programmes for people with diabetes.
However, systematic review of studies where blood pres-
sure was reported, showed similar reductions in SBP
(standard effect size of 0.2) [24]. The effect sizes observed
are relatively moderate, about one-third the size of those
of antihypertensive drugs [26].
The effects of intervention on BMI were modest in
comparison to the results of behavioural modification
trials. A lifestyle intervention offered to people with type
2 diabetes in the Look Ahead trial found that among
patients with an average BMI of 35, at one year, the per-
centage loss in body weight was 8% higher in the inter-
vention group [27] (which is equivalent to a difference
Table 1 Characteristics of included patients
Characteristic Birmingham Own
Health
Intervention
®
(included in
analyses)
GPRD
comparison
(usual care)
N 473 21,052
Mean age (SD) 62.4 (13.0) 62.8 (12.7)
Sex
Male 263 (55.6%) 11,820 (56.2%)
Female 210 (44.4%) 9232 (43.9%)
Smoking status
Never smoker 175 (37.0%) 8661 (41.4%)
Ex-smoker 157 (33.2%) 9134 (43.4%)
Current smoker 75 (15.9%) 3144 (14.9%)
Unknown 66 (14.0%) 113 (0.5%)
Deprivation quintile of
practice
1 (least deprived) 9 (1.9%) 3479 (16.5%)
2 0 2532 (12.0%)
3 0 4401 (20.9%)
4 90 (19.0%) 4174 (19.8%)
5 (most deprived) 374 (79.1%) 6466 (30.7%)
Other conditions
Coronary Heart Disease 160 (33.8%) 3646 (17.3%)
Congestive Heart Failure 15 (3.2%) 470 (2.2%)
Asthma 36 (7.6%) 2948 (14.0%)
Depression 97 (20.5%) 3545 (16.8%)
Stroke 24 (5.1%) 848 (4.0%)
COPD 9 (1.9%) 695 (3.3%)
Medications
Betablockers 123 (26.0%) 5217 (24.8%)
Thiazides* 178 (37.6%) 5769 (27.4%)
Statins 333 (70.4%) 15,202 (72.2%)
Digoxin/digitoxin 18 (3.8%) 437 (2.1%)
Insulin 170 (35.9%) 5505 (26.2%)
* For the Birmingham Own Health
® Intervention this includes all diuretics.
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dual). In our study, we observed overall smaller reduc-
tions, although with effects of this magnitude among
those with morbid obesity (BMI ≥ 40). The difference in
BMI between Birmingham Own Health
® and control
participants in this category was equivalent to about 7%
of initial body weight at follow up. This is likely to lead
to significant health benefits in terms of glucose control
and reduction in risk of cardiovascular events [28].
Strengths and limitations
Although not randomised, this study used a novel
approach for comparing the intervention group with
matched controls from the general population in a pri-
mary care setting. The approach for identifying controls
from GPRD is relatively unique, and the large number
of controls from a wide population base increases the
power of the study. The benefit of having a control
group is evident from a comparison of mean change in
clinical measures from baseline to follow-up, with the
adjusted mean difference between groups. Using pre/
post intervention changes only shows generally much
larger effect sizes, which are partly due to regression to
the mean. The inclusion of a control group provides a
more realistic estimate of effect size, which is slightly
attenuated. The Birmingham Own Health
® intervention
is novel in targeting people from the most deprived
communities, who are traditionally hard to reach. A
recent analysis of the impact of the Quality Outcomes
Framework indicated that it has led to improved quality
of care in more deprived practices [29], but may not
have resulted in improved health in those most deprived
or indeed reduced inequalities in health. The Birming-
ham Own Health intervention appeared to be effective
in the most deprived areas and therefore has potential
to be of benefit in improving the health of those least
well off. A caveat is that the measure of deprivation is at
area level rather than individual level, so this effect can-
not necessarily be assumed. The use of telephone inter-
vention overcomes many of the barriers reported for
Table 2 Effect of Birmingham Own Health
® Intervention on HbA1c values among people with diabetes
Intervention Control Multivariate linear
regression coefficients
(95%CI)
N 296 3454
Mean age (years) (SD) 61.6 (13.1) 63.5 (11.6) -0.007 (-0.01, -0.004)
Males (n (%)) 155 (52.4%) 1828 (52.9%) -0.03 (-0.10, 0.04)
Smoking status
Never smoker 118 (39.9) 1403 (40.6%) 1.0
Ex-smoker 88 (29.7) 1601 (46.4%) 0.008 (-0.07, 0.08)
Current smoker 42 (14.2%) 450 (13.0%) 0.02 (-0.08, 0.13)
Unknown 48 (16.2%) -
Length of follow-up (days)
Mean (SD) 331.9 (136.2) 336.3 (132.9) 0.0002 (-0.0001,
Median (IQR) 328 (216-449) 345 (219-441) 0.0004)
Baseline HbA1c (%) Mean (SD) 8.2 (1.8) 7.7 (1.5) 0.70 (0.68, 0.73)
Sub-groups (n (%))
< 7.0% 73 (24.7%) 1156 (33.5%)
7.0-7.9% 86 (29.1%) 1106 (32.0%)
8.0-8.9% 59 (19.9%) 620 (18.0%)
> 9.0% 78 (26.4%) 572 (16.6%)
Final value (mean) (SD) 7.8 (1.6) 7.7 (1.5)
Mean change (SD) -0.4 (1.4) -0.03 (1.1)
Difference in final values (intervention - control) (95% CI) +0.11 (-0.07, 0.29)
Adjusted mean difference in final HbA1c values between intervention and control (%) (95%CI)* -0.25 (-0.38, -0.11)
Adjusted mean difference in final HbA1c values between intervention and control by sub-group of baseline values (95%CI)
(%)
< 7.0% 0.2 (-0.01, 0.4)
7.0-7.9% -0.3 (-0.6, -0.1)
8.0-8.9% -0.3 (-0.6, 0.1)
> 9.0% -0.6 (-1.0, -0.2)
* adjusted for age, sex, baseline values, smoking status, length of follow-up.
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namely travel, inconvenience and timing of sessions
[30]. Furthermore, the range of clinical indicator out-
comes measured is wider than those in some previous
studies.
On the other hand, lack of randomisation is an impor-
tant potential source of selection bias. We minimised
this by matching controls to cases as closely as possible
in relation to broad inclusion and exclusion criteria, to
baseline test values and to the dates when these were
Table 3 Effect of Birmingham Own Health
® Intervention on diastolic and systolic blood pressure among people with
diabetes
Intervention Control Multivariate linear regression coefficients (95%CI)
Diastolic blood pressure Systolic blood pressure
N 288 4789
Mean age (years) (SD) 63.3 (12.4) 65.3 (11.2) -0.13 (-0.15, -0.11) 0.12 (0.08, 0.16)
Males (n (%)) 155 (53.8%) 2532 (52.9%) 0.26 (-0.26, 0.79) -0.12 (-1.02, 0.78)
Smoking status
Never smoker 119 (41.3%) 1963 (41.0%) 1.0 1.0
Ex-smoker 99 (34.4%) 2256 (47.1% -0.55 (-1.11, 0.006) -0.07 (-1.03, 0.89)
Current smoker 34 (11.8%) 570 (11.9%) -1.36 (-2.20, -0.51) 0 (-1.44, 1.44)
Unknown 36 (12.5%) -
Length of follow-up (days)
Mean (SD) 321.6 (143.4) 325.7 (139.5) -0.0006 (-0.002, 0.001) 0.001 (-0.002, 0.004)
Median (IQR) 321 (184, 445.5) 338 (198, 440)
Baseline diastolic blood pressure (mmHg) Mean (SD) 8.2 (1.8) 7.7 (1.5) 0.38 (0.36, 0.41) -
Sub-groups (n (%))
< 80 mmHg 145 (50.3%) 2645 (55.2%)
80-89 mmHg 107 (37.2%) 1688 (35.2%)
90-99 mmHg 24(8.3%) 385 (8.0%)
> 100 mmHg 12 (4.2%) 71 (1.5%)
Baseline systolic blood pressure (mmHg) Mean (SD) 139.6 (18.0) 138.3 (14.6) - 0.39 (0.36, 0.42)
Sub-groups (n (%))
< 120 mmHg 27 (9.4%) 341 (7.1%)
120-129 mmHg 48 (16.7%) 755 (15.8%)
130-139 mmHg 80 (27.8%) 1346 (28.1%)
140-149 mmHg 71 (24.7%) 1389(29.0%)
> 150 mmHg 62 (21.5%) 958 (20.0%)
Final value (mean) (SD) (mmHg)
Diastolic blood pressure 75.2 (9.3) 76.1 (10.2)
Systolic blood pressure 134.6 (15.9) 137.6 (16.8)
Mean change (SD) (mmHg)
Diastolic blood pressure -3.3 (11.7) -0.6 (10.8)
Systolic blood pressure -5.0 (19.0) -0.7 (17.8)
Difference in final values (mmHg)
(intervention - control) (95% CI)
Diastolic blood pressure -0.9 (-2.1, 0.3)
Systolic blood pressure -3.0 (-5.0, -1.0)
Adjusted mean difference in final blood pressure
between intervention and control*
(mmHg) (95%CI)
-1.6 (-2.7, -0.4) -3.5 (-5.5, -1.5)
Adjusted mean difference in final blood pressure between
intervention and control by sub-group of baseline values
(95%CI) (mmHg)
< 80 mmHg -1.0 (-2.6, 0.6)
80-89 mmHg -1.6 (-3.5, 0.3)
90-99 mmHg -3.1 (-7.7, 1.5)
≥ 100 mmHg -0.1 (-8.4, 8.2)
< 120 mmHg -1.9 (-8.1, 4.4)
120-129 mmHg -2.7 (-7.4, 1.9)
130-139 mmHg -1.6 (-5.2, 2.0)
140-149 mmHg -4.6 (-8.5, -0.8)
≥ 150 mmHg -5.4 (-10.4, -0.4)
* adjusted for age, sex, baseline values, smoking status, length of follow-up.
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the analyses, thus minimising further the effect of any
bias. Nevertheless we were only able to match on lim-
ited measures and it is possible that cases and controls
differed in other ways that we have not captured. In fact
cases and controls did differ in relation to comorbidities,
but this was difficult to control because of poor record-
ing of conditions in both cases and controls. Similarly
recording errors for other confounding factors including
medications and smoking make adjustment unreliable.
The “opt-out” system may also have meant that the
most motivated patients joined the intervention, poten-
tially overestimating the effects of the intervention.
The way in which follow up data was obtained differed
between cases and controls. For GPRD controls, these
measures were taken from GP record data. However Bir-
mingham Own Health
® participants reported the mea-
sures themselves, and social acceptability bias is a
possibility. Although a number of outcome measures
were included, some important measures, such as change
in smoking status or exercise levels were not recorded.
This limits the measure of effectiveness and the wider
potential effects of the intervention. It is also important
to consider that “usual care” in the control group is not
uniform, and may have also changed over time. Thus the
effectiveness of the Birmingham Own Health
® interven-
tion is not in comparison to no intervention. By selecting
controls with measures taken within +/- 90 days of the
intervention participants, the effects of change in back-
ground levels of “usual care” was avoided.
Conclusions
Despite the limitations of the study design, the results are
consistent with the Birmingham Own Health
® telephone
care management intervention being effective in reducing
HbA1c levels, blood pressure and BMI in people with dia-
betes, and importantly, to a degree comparable with ran-
domised controlled trials of similar interventions. The
Table 4 Effect of Birmingham Own Health
® Intervention on serum cholesterol among people with diabetes
Intervention Control Multivariate linear regression
coefficients (95%CI)
N 239 1961
Mean age (years) (SD) 63.1 (11.7) 64.4 (10.9) -0.001 (-0.005, 0.002)
Males (n (%)) 129 (54.0) 1024 (52.2) -0.15 (-0.22, -0.08)
Smoking status
Never smoker 87 (36.4%) 824 (42.0) 1.0
Ex-smoker 92 (38.5%) 906 (46.2) -0.03 (-0.11, 0.04)
Current smoker 29 (12.1% 231 (11.8) 0.01 (-0.10, 0.12)
Unknown 31 (13.0%) -
Length of follow-up (days)
Mean (SD) 322.7 (134.4) 330.4 (122.9) -0.0001 (-0.0004, 0.0002)
Median (IQR) 313 (215, 419) 343 (235, 405)
Baseline serum cholesterol (mmol/l) Mean (SD) 4.3 (1.0) 4.4 (1.0) 0.60 (0.56, 0.63)
Sub-groups (n (%))
< 4 mmol/l 88 (36.8%) 656 (33.5%)
4.0-4.9 mmol/l 82 (34.3%) 787 (40.1%)
5.0-5.9 mmol/l 46 (19.2%) 310 (15.8%)
6.0-6.9 mmol/l 9 (3.8%) 75 (3.8%)
> 7.0 mmol/l 3 (1.3%) 33 (1.7%)
Final serum cholesterol (mmol/l) (mean) (SD) 4.1 (1.1) 4.3 (1.0)
Mean change in serum cholesterol (mmol/l) (SD) -0.2 (1.0) -0.1 (0.9)
Difference in final serum cholesterol (intervention - control) (95% CI) -0.2 (-0.3, -0.0)
Adjusted mean difference in final serum cholesterol between intervention and control (mmol/l)(95%CI)* -0.1 (-0.2, -0.1)
Adjusted mean difference in final serum cholesterol between intervention and control by sub-group of baseline
values (mmol/l) (95%CI)
< 4 mmol/l 0.0 (-0.2, 0.2)
4.0-4.9 mmol/l -0.3 (-0.5, -0.1)
5.0-5.9 mmol/l -0.0 (-0.3, -0.3)
6.0-6.9 mmol/l -0.1 (-0.9, 0.7)
> 7.0 mmol/l -0.7 (-2.6, 1.2)
* adjusted for age, sex, baseline values, smoking status, length of follow-up.
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Page 9 of 11effects appear to be greater in patients with poorer base-
line levels and the intervention appears effective in the
most deprived populations. The levels of change observed
are associated with reductions in expected all-cause and
cardiovascular mortality, based on observational studies.
Although the cost-effectiveness of this intervention is not
known, economic evaluation of another telephone self-
management intervention for people with diabetes found
that the cost per QALY was favourable compared to other
established diabetes prevention and treatment interven-
tions [31]. This novel methodology appears to offer a rela-
tively cheap alternative to RCTs.
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